Not available
Quote | Cullinan Oncology Inc. (OTCMKTS:CGEM)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $0.02 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 10/25/2019 04:53:23 pm |
News | Cullinan Oncology Inc. (OTCMKTS:CGEM)
2024-06-30 11:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-09 09:44:11 ET Summary Cullinan Therapeutics, Inc. has seen a recent pullback in its shares, but they are still up 50% since mid-April after rebranding and focusing on autoimmune diseases. The company's lead asset is zipalertinib, an oral EGFR inhibitor being evaluated in ...
Message Board Posts | Cullinan Oncology Inc. (OTCMKTS:CGEM)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CGEM News Article - Cullinan Oncology and Taiho Pharmaceutical Complete Agreement for | whytestocks | investorshangout | 06/23/2022 7:41:00 PM |
whytestocks: $CGEM News Article - Cullinan Oncology to Participate in Upcoming Virtual Healthcare Co | whytestocks | investorshangout | 04/05/2022 12:11:01 PM |
whytestocks: $CGEM News Article - Cullinan Oncology to Present at the Barclays Global Healthcare Con | whytestocks | investorshangout | 03/09/2022 9:11:19 PM |
whytestocks: $CGEM News Article - Cullinan Oncology Provides Corporate Update and Reports Second Qua | whytestocks | investorshangout | 08/10/2021 6:05:48 PM |
whytestocks: $CGEM News Article - Cullinan Oncology Announces Phase 1/2a Interim Data For Cullinan P | whytestocks | investorshangout | 06/04/2021 2:05:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Cullinan Oncology Inc. Company Name:
CGEM Stock Symbol:
OTCMKTS Market:
Cullinan Oncology Inc. Website:
2024-06-30 11:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CAMBRIDGE, Mass., June 01, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc . (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced positive initial data in patients receiving zipalertinib after prior treatment with amivanta...
2024-05-29 21:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...